From: Risk factors for postoperative complications in patients with pulmonary tuberculosis
Factors | PAL | p | PE | p | PRS | P | |||
---|---|---|---|---|---|---|---|---|---|
Absent N = 175 | Present N = 29 |  | Absent N = 181 | Present N = 23 |  | Absent N = 177 | Present N = 27 |  | |
Sex | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Male | 112 (64.0%) | 26 (89.7%) | 0.012 | 119 (65.7%) | 19 (82.6%) | 0.164 | 117 (66.1%) | 21 (7.8%) | 0.227 |
 Female | 63 (36.0%) | 3 (10.3%) |  | 62 (34.3%) | 4 (17.4%) |  | 60 (33.9%) | 6 (22.2%) |  |
Age, years, median (IQR) | 49 (32–59) | 47 (33–60.5) | 0.908 | 50 (32–59) | 40 (32–63) | 0.726 | 49 (32–57) | 60 (35–66) | 0.022 |
BMI, kg/m2,median (IQR) | 21.9 (21.0–22.9) | 22.3 (20.9–23.3) | 0.642 | 21.9 (21.0–22.9) | 21.7 (20.7–23.3) | 0.730 | 21.9 (21.0–22.9) | 21.8 (20.4–23.2) | 0.437 |
ASA grade | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 2 | 116 (66.3%) | 16 (55.2%) | 0.246 | 119 (65.7%) | 13 (56.5%) | 0.383 | 120 (67.8%) | 12 (44.4%) | 0.018 |
 3 | 59 (33.7%) | 13 (44.8%) |  | 62 (34.3%) | 10 (43.5%) |  | 57 (32.2%) | 15 (55.6%) |  |
Previous COVID-19 status | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Uninfected | 71 (40.6%) | 11 (37.9%) |  | 74 (40.9%) | 8 (34.8%) |  | 76 (42.9%) | 6 (22.2%) |  |
 Asymptomatic infections | 75 (42.9%) | 14 (48.3%) | 0.848 | 77 (42.5%) | 12 (52.2%) | 0.679 | 75 (42.4%) | 14 (51.9%) | 0.090 |
 Mildly infected | 29 (16.6%) | 4 (13.8%) |  | 30 (16.6%) | 3 (13.0%) |  | 26 (14.7%) | 7 (25.9%) |  |
Smoking (Index) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Heavy smoker | 16 (9.1%) | 3 (10.3%) |  | 17 (9.4%) | 2 (8.7%) | 0.496 | 16 (9.0%) | 3 (11.2%) |  |
 Light smoker | 112 (64.0%) | 15 (51.7%) | 0.436 | 115 (63.5%) | 12 (52.2%) |  | 115 (65.0%) | 12 (44.4%) | 0.105 |
 Moderate smoker | 47 (26.9%) | 11 (37.9%) |  | 49 (27.1%) | 9 (39.1%) |  | 46 (26.0%) | 12 (44.4%) |  |
 FEV1%, median (IQR) | 84.3 (79.7–87.9) | 85.8 (80.9–87.7) | 0.437 | 84.3 (79.9–87.9) | 86.2 (78.5–87.4) | 0.970 | 85.3 (79.9–87.7) | 84.3 (78.5–88.0) | 0.729 |
Adhesion grade | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Mild | 111 (63.4%) | 9 (31.0%) | 0.001 | 117 (64.6%) | 3 (13.0%) | 0.000 | 114 (64.4%) | 6 (22.2%) | 0.000 |
 Severe | 64 (36.6%) | 20 (69.0%) |  | 64 (35.4%) | 20 (87.0%) |  | 63 (35.6%) | 21 (77.8%) |  |
DB | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Present | 25 (14.3%) | 2 (6.9%) | 0.429 | 23 (12.7%) | 4 (17.4%) | 0.766 | 22 (12.4%) | 5 (18.5%) | 0.384 |
 Absent | 150 (85.7%) | 27 (93%) |  | 158 (87.3%) | 19 (82.6%) |  | 155 (87.6%) | 22 (81.5%) |  |
HP | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Present | 21 (12.0%) | 1 (34%) | 0.293 | 21 (11.6%) | 1 (4.3%) | 0.484 | 20 (11.3%) | 2 (7.4%) | 0.784 |
 Absent | 154 (88.0%) | 28 (96.6%) |  | 160 (88%) | 22 (95.7%) |  | 157 (88.7%) | 25 (92.6%) |  |
Hemoptysis | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Present | 70 (40.0%) | 16 (55.2%) | 0.125 | 70 (38.7%) | 16 (69.6%) | 0.005 | 68 (38.4%) | 18 (66.7%) | 0.006 |
 Absent | 105 (60.0%) | 13 (44.8%) |  | 111 (61.3%) | 7 (30.4%) |  | 109 (61.6%) | 9 (33.3%) |  |
Pre BAE | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Yes | 10 (5.7%) | 1 (3.4%) | 0.955 | 8 (4.4%) | 3 (13.0%) | 0.217 | 7 (4.0%) | 4 (14.8%) | 0.062 |
 No | 165 (94.3%) | 28 (96.6%) |  | 173 (95.6%) | 20 (87.0%) |  | 170 (96.0%) | 23 (85.2%) |  |
 ATB Time, days, median (IQR) | 60 (0–210) | 0 (0–225) | 0.454 | 60 (0–225) | 0 (0–150) | 0.189 | 60 (0–240) | 0 (0–120) | 0.096 |
 Maximum diameter, cm, median (IQR) | 5 (3–8) | 7 (5–9) | 0.032 | 5 (3–8) | 9 (6–10) | 0.001 | 5 (3–7) | 8 (5–10) | 0.001 |
 WBC, × 109/L, median (IQR) | 5.65 (4.36–7.45) | 5.47 (4.36–6.91) | 0.950 | 5.58 (4.34–7.13) | 6.18 (4.45–8.74) | 0.222 | 5.60 (4.38–7.30) | 5.78 (4.34–7.75) | 0.946 |
 ESR, mm/h, median (IQR) | 13 (6–29) | 13 (6–20) | 0.706 | 12 (6–25) | 16 (8–33) | 0.176 | 13 (6–26.5) | 13 (7–30) | 0.593 |
 HCRP, mg/L, median (IQR) | 1.71 (076–6.42) | 2.64 (0.97–13.86) | 0.388 | 1.69 (0.74–6.76) | 2.40 (1.30–11.49) | 0.196 | 1.61 (0.74–6.49) | 2.13 (1.30–13.33) | 0.130 |
Location | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 R | 80 (45.7%) | 12 (41.4%) | 0.664 | 82 (45.3%) | 10 (43.5%) | 0.868 | 80 (45.2%) | 12 (44.4%) | 0.942 |
 L | 95 (54.3%) | 17 (58.6%) |  | 99 (54.7%) | 13 (56.5%) |  | 97 (54.8%) | 15 (55.6%) |  |
Operative approach | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 VATS | 130 (74.3%) | 18 (62.1%) | 0.172 | 132 (72.9%) | 16 (69.6%) | 0.734 | 125 (70.6%) | 23 (85.2%) | 0.178 |
 OS | 45 (25.7%) | 11 (37.9%) |  | 49 (27.1%) | 7 (30.4%) |  | 52 (29.4%) | 4 (14.8%) |  |
Operative procedure | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Sublobectomy (Seg/wedge) | 65 (37.1%) | 7 (24.1%) | 0.175 | 69 (38.1%) | 3 (13.0%) | 0.032 | 68 (38.4%) | 4 (14.8%) | 0.030 |
 Lobectomy (Lob/Lob + Seg/Lob + wedge/Pneumo) | 110 (62.9%) | 22 (75.9%) |  | 112 (61.9%) | 20 (87.0%) |  | 109 (61.6%) | 23 (85.2%) |  |
 Operative times, min, median (IQR) | 195 (120–275) | 345 (227.5–380) | 0.001 | 205 (125–282.5) | 345 (250–445) | 0.001 | 200 (120–282.5) | 325 (205–395) | 0.001 |
 Operative bleeding, ml, median (IQR) | 200 (50–500) | 450 (250–1100) | 0.001 | 200 (50–450) | 750 (400–1300) | 0.001 | 200 (50–400) | 1000 (300–1300) | 0.001 |
Transfer blood | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Yes | 23 (13.1%) | 8 (27.6%) | 0.045 | 22 (12.2%) | 9 (39.1%) | 0.001 | 17 (9.6%) | 14 (51.9%) | 0.001 |
 No | 152 (86.9%) | 21 (72.4%) |  | 159 (87.8%) | 14 (60.9%) |  | 160 (90.4%) | 13 (48.1%) |  |